News | Personalised medicine

News

Diabetes medicines spend rises by almost 20% in one year

NHS Business Services Authority data have also revealed that almost 1 million patients received diabetes medicines in the most deprived areas of England in 2024/2025.…

Published: 26 August 2025

News

NICE draft guidance ‘biggest shake-up’ to type 2 diabetes treatment in a decade

The National Institute for Health and Care Excellence said these changes are aimed to address underprescribing and health inequalities related to treatment for type 2 diabetes mellitus.…

Published: 20 August 2025

News

RPS asked for clarification on dispensing timelines following death of patient with diabetes

A coroner has issued a ‘Prevention of future deaths’ report seeking information on a repeat prescribing toolkit published by the Royal Pharmaceutical Society and Royal College of GPs.…

Published: 23 June 2025

News

MHRA publishes ‘world first’ decentralised manufacturing guidance

The guidance will inform the manufacture of medicines with a short shelf-life or highly personalised medicines at sites within or in close proximity to hospitals.…

Published: 13 June 2025

Feature

Net zero: progress on reducing the environmental impact of medicines

Although some progress has been made towards reducing the carbon footprint of medicines within the NHS, experts say there needs to be more focus on medicines waste and disease prevention.…

Published: 14 May 2025

News

Standard-dose DOACs not necessarily better than reduced dose, study results suggest

Researchers found that “non-inferiority” of a reduced dose of direct oral anticoagulants could not be determined when compared with a standard dose, with “reliably low rates” of recurrent venous thromboembolism.…

Published: 4 March 2025

News

Fewer than 20% of type 2 diabetes patients on most effective medicine for them, model shows

The model was also associated with a 38% reduction in the likelihood of glycaemic failure over five years.…

Published: 28 February 2025

Feature

Engineering precision: developing the next generation of antibody drug conjugates

Researchers are working to create a new generation of these targeted cancer therapies to improve efficacy and minimise off-target adverse effects.…

Published: 15 January 2025

News

One-quarter of patients in pharmacogenomics trial have had prescriptions changed

Around 25% of the 400 participants of the 'Progress programme' have been advised to change their prescription following genetic testing.…

Published: 11 November 2024

News

CAR-T infusions delivered to ‘more than 80’ patients in Wales, says NHS Wales

The NHS Wales Joint Commissioning Committee has enabled 100 patients in Wales to receive an advanced therapy medicinal product to date.…

Published: 21 October 2024